Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
12/28/1999 | CA1340861C Cysteine-depleted muteins of biologically active proteins |
12/23/1999 | WO1999066036A1 Transplants for myocardial scars |
12/23/1999 | WO1999066031A2 Pharmaceutical factor vii preparation |
12/23/1999 | WO1999065507A1 Modulating platelet function |
12/23/1999 | WO1999065505A1 Oregano for the treatment of internal parasites and protozoa |
12/23/1999 | WO1999065503A1 Method of treating osteogenesis imperfecta |
12/23/1999 | WO1999065470A1 Particulate acellular tissue matrix |
12/23/1999 | WO1999049881A3 Application of hsp70 proteins |
12/23/1999 | WO1999049876A3 Bacterial or yeast extracts which stimulate the production of defensins and methods of use thereof |
12/23/1999 | WO1999028748A3 Hla-e binding |
12/23/1999 | DE19826928A1 Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen Drugs, viable anaerobic bacteria containing inhibit sulfate reduction of sulfate-reducing bacteria |
12/23/1999 | CA2335248A1 Transplants for myocardial scars |
12/22/1999 | EP0965640A1 GP75 as a tumor vaccine for melanoma |
12/22/1999 | EP0965639A1 Attenuated pestiviruses |
12/22/1999 | EP0965595A1 Protein complex |
12/22/1999 | EP0965351A2 Pharmaceutical composition for treating side-effects of a diet with reduced amount of carbohydrates |
12/22/1999 | EP0965347A2 Use of viable anaerobic bacteria for the preparation of a medicament for inhibiting the growth of sulphate reducing bacteria |
12/22/1999 | EP0965278A1 Dietetic food composition and dietetic method using such composition |
12/22/1999 | EP0964925A2 A basal cell carcinoma tumor suppressor gene |
12/22/1999 | EP0964901A1 Coal tar extract with reduced aromatic hydrocarbon content, method for obtaining same and dermatological and cosmetic compositions |
12/22/1999 | EP0964868A1 Isolated peptides derived from mage-2 |
12/22/1999 | EP0964694A1 Mucin-mediated immunomodulation |
12/22/1999 | EP0964691A1 Use of conantokins |
12/22/1999 | EP0964689A1 Recombinant vaccine for diseases caused by encapsulated organisms |
12/22/1999 | EP0964686A1 Methods and compositions for preventing or retarding the development of atherosclerotic lesions |
12/22/1999 | CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4) |
12/22/1999 | CN1238989A Medicine for curing infantile malnutrition and its preparing process |
12/22/1999 | CN1238987A Chinese medicine for treating digestive tract inflammation and ulcer |
12/22/1999 | CN1238984A Medicine for treating facial paralysis and its preparing method |
12/22/1999 | CN1238982A Chinese patent medicine for treating gastrosis |
12/22/1999 | CN1238924A Nutritive health-care aloe beverage |
12/22/1999 | CN1238907A Process for extracting scorpion toxin |
12/22/1999 | CN1047534C Scar-eliminating scald ointment |
12/22/1999 | CN1047531C Plaster for treatment of spur and its prepn. process |
12/22/1999 | CN1047529C Medicine for treatment of piles |
12/22/1999 | CN1047526C Processing method of carbon haemostatic powder |
12/22/1999 | CN1047524C Chinese patent medicine for treatment of brain trauma syndrome |
12/22/1999 | CN1047523C Nearsight prevention eye drop solution |
12/22/1999 | CN1047522C Method for refining aqueous extract of traditional Chinese medicine |
12/21/1999 | US6004813 Il-6 activity inhibitor |
12/21/1999 | US6004812 In-vitro T-lymphopoiesis system |
12/21/1999 | US6004811 Isolated cytotoxic t-cell which expresses a membrane-bound chimeric receptor which binds target cell and signals to destroy bound target cell; targets infected, cancerous, tumor or autoimmune-generated cells |
12/21/1999 | US6004803 Genes encoding HSV1-TK containing a deletion of 5' cryptic promoter sites, vectors and cell lines |
12/21/1999 | US6004794 Human serine protease |
12/21/1999 | US6004777 Vectors having enhanced expression, and methods of making and uses thereof |
12/21/1999 | US6004551 Lactobacillus, skim milk, lactobacillus growth factor (lgf) and lactobacillus compositions which adhere to biomaterials, intestinal, vaginal and uroepithelial cells, to resist the action of certain anti-microbial agents |
12/21/1999 | US6004550 Intracellular expression of carboxypeptidase G2 in a nitrogen mustard prodrug system |
12/21/1999 | CA2197075C Method of gene therapy using dna vectors without selection marker gene |
12/21/1999 | CA2091557C Intestine colonizing lactobacilli |
12/21/1999 | CA2065842C Process for inactivating viruses in blood and blood products |
12/21/1999 | CA1340853C Purification of recombinant interleukin-2 |
12/16/1999 | WO1999064628A1 Detection of dna, rna and proteins |
12/16/1999 | WO1999064604A2 Attenuated pestiviruses |
12/16/1999 | WO1999064577A1 Novel adenoviral vectors for gene therapy |
12/16/1999 | WO1999064571A1 Interferon inducing genetically engineered attenuated viruses |
12/16/1999 | WO1999064570A1 Novel methods and interferon deficient substrates for the propagation of viruses |
12/16/1999 | WO1999064565A2 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
12/16/1999 | WO1999064068A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
12/16/1999 | WO1999064024A2 Use of adeno-associated viruses for decreasing the radiotherapy-induced or chemotherapy-induced resistance in cancer patients |
12/16/1999 | WO1999064023A1 Lactic acid bacterium-containing compositions, drugs and foods |
12/16/1999 | WO1999064022A1 Prophylactic and therapeutic nutritional supplement for creation/maintenance of health-protective intestinal microflora and enhancement of the immune system |
12/16/1999 | WO1999064021A1 hCEPR RECEPTOR |
12/16/1999 | WO1999055348A3 Stabilised virus preparation |
12/16/1999 | WO1999054354A9 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it |
12/16/1999 | WO1999052546A3 A method of inducing an anti-tumor response against a lung metastasis in a melanoma patient |
12/16/1999 | WO1999049877A3 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions |
12/16/1999 | WO1999049015A3 Cardiac-derived stem cells |
12/16/1999 | WO1999046380A3 Human membrane spanning proteins |
12/16/1999 | WO1999041368A3 Optimization of immunomodulatory properties of genetic vaccines |
12/16/1999 | WO1999006540A3 Inhibitors of cell-cycle progression and uses related thereto |
12/16/1999 | CA2680649A1 Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells |
12/16/1999 | CA2334895A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
12/16/1999 | CA2334850A1 Novel methods and interferon deficient substrates for the propagation of viruses |
12/16/1999 | CA2334370A1 Lactic acid bacterium-containing compositions, drugs and foods |
12/16/1999 | CA2329947A1 Novel adenoviral vectors for gene therapy |
12/15/1999 | EP0963441A1 Inactivation of hiv co-receptors as therapy for hiv infection |
12/15/1999 | EP0963440A1 Improved methods for transducing cells |
12/15/1999 | EP0963431A1 NOVEL FabH |
12/15/1999 | EP0812201A4 -i(IN VITRO) AMPLIFICATION OF STEM CELLS |
12/15/1999 | EP0587840B1 Bioartificial endocrine device |
12/15/1999 | CN1238807A Stabilized transient gene expression |
12/15/1999 | CN1238782A Colostrinin and uses thereof |
12/15/1999 | CN1238697A Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype |
12/15/1999 | CN1238380A Forest frog wine |
12/15/1999 | CN1238216A Oral immunity enhancing agent |
12/15/1999 | CN1238215A Agent having untitumor activity |
12/15/1999 | CN1238212A Liquid medicine for treating disseases of eye, ear, nose and throat |
12/15/1999 | CN1238207A Tonic liquid of black ewe's placenta extract and its preparing method |
12/15/1999 | CN1238201A Shenkangsan-medicine for treating nephrosis |
12/15/1999 | CN1238200A Medical capsule for regulating insulin and reducing blood and/or uric sugar |
12/15/1999 | CN1238189A Medicine for treating burn and scald |
12/15/1999 | CN1238186A Medicine for curing hemiplegia and its preparing process |
12/15/1999 | CN1238185A Medical capsule prepared with snake, soft-shelled turtle and royal jelly and its preparing process |
12/15/1999 | CN1238184A Method for raising pigs and promoting them stronger |
12/15/1999 | CN1047316C Shezhu eye drop with visual improving function |
12/15/1999 | CN1047312C Medicine for curing asthma and its preparation method |
12/15/1999 | CN1047311C Traditional Chinese medicine for treatment of paraplegia |
12/14/1999 | US6001998 Macrocyclic lactone compounds and their production process |
12/14/1999 | US6001987 Isolated nucleotide sequences associated with Multiple sclerosis |
12/14/1999 | US6001882 Photoactivated hypericin and the use thereof |